General practitioners' advice to use topical rather than oral ibuprofen resulted in equivalent effects on chronic knee pain STUDY DESIGN Design: randomised controlled trial (Topical or Oral Ibuprofen [TOIB]). Allocation: concealed.* Blinding: blinded (data collectors).*
STUDY QUESTION
Setting: 26 general practices in the UK. Patients: 282 patients >50 years of age (mean age 63 y, 54% women) with knee pain (97% with osteoarthritis). Exclusion criteria included history of, or awaiting, knee replacement, and recent knee injury. Intervention: the patient's general practitioner prescribed or recommended preferential use of over-the-counter topical ibuprofen, applied according to manufacturer's instructions (eg, 0.5 g per knee up to 3 times/d, equivalent to 75 mg/d of ibuprofen using a 5% preparation) (n = 138), or oral ibuprofen, up to 1.2 g/day (n = 144). Increased dose, additional painkillers, or alternate non-steroidal antiinflammatory drugs (NSAIDs) were allowed, but maintaining the allocated route was encouraged. Outcomes: primary outcomes were the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score and adverse effects. The study had .80% power to show equivalence in WOMAC scores to within 10 mm (a = 0.05).
Follow-up period: 12 months. Patient follow-up: 88% (intention-to-treat analysis).
MAIN RESULTS
Groups did not differ for change in WOMAC scores (table) . Proportions of patients with >1 unplanned hospital admission were similar (4.4% in the topical group v 1.4% in the oral group, p = 0.16); no death or episode of gastric bleeding occurred in either group. Patients in the topical group had a lower rate of minor respiratory adverse effects (7% v 17%, p = 0.02), but groups did not differ for minor gastrointestinal (42% v 40%) or renovascular (16% v 15%) adverse effects.
CONCLUSION
In older patients with chronic knee pain, general practitioners' advice to use topical rather than oral ibuprofen resulted in equivalent effects on knee pain. Advice from general practitioners to use topical v oral ibuprofen for chronic knee pain NSAIDs reduce pain more than paracetamol, especially in severe osteoarthritis, but with increased incidence of gastrointestinal adverse effects. 1 A 2004 systematic review of topical NSAIDs found that they were superior to placebo for osteoarthritis in the first 2 weeks of treatment but not at weeks 3 or 4 (the maximum length of the trials). 2 However, 2 subsequent manufacturer-sponsored trials in patients with knee osteoarthritis showed that topical diclofenac reduced WOMAC pain scores more than placebo at 4 and 12 weeks, respectively. 3 4 The trial by Underwood et al is the first long-term study comparing an oral with a topical NSAID, ibuprofen. The trial was designed to show equivalence, rather than superiority; the authors concluded that there was no difference in effectiveness. However, the more important finding may be that there was little difference between mean baseline and 12-month WOMAC scores for both preparations (eg, change for global assessment was +2 with topical and -2 with oral ibuprofen). In the absence of a placebo group, it is impossible to conclude whether the 2 treatments were equally mildly effective or equally ineffective.
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